关于 "VEGFR" 的结果10 个结果
筛选:c-MET×
- Cabozantinib (XL184, BMS-907351)CAS: 849217-68-1
Cabozantinib (XL184,BMS-907351) 是一种新型 MET 和 VEGFR2 抑制剂,可同时抑制转移、血管生成和肿瘤生长。
- Foretinib (GSK1363089)CAS: 849217-64-7
Foretinib (GSK1363089)是一种多靶点受体酪氨酸激酶抑制剂,其主要靶点包括c-Met(IC 50 =0.4nM)和VEGFR2(IC 50 =0.9nM)。
c-MET
| 货号 | 产品名称 | CAS号 | 靶点 / 通路 | 引用 | 结构 |
|---|---|---|---|---|---|
| GC15307 | SU5416 | 204005-46-9,194413-58-6 | FLT3 | ||
SU5416 是一种有效的小分子血管内皮生长因子受体 (VEGFR) 抑制剂。 | |||||
| GC15779 | Cabozantinib (XL184, BMS-907351) | 849217-68-1 | Other Apoptosis | ||
Cabozantinib (XL184,BMS-907351) 是一种新型 MET 和 VEGFR2 抑制剂,可同时抑制转移、血管生成和肿瘤生长。 | |||||
| GC13598 | MGCD-265 | 875337-44-3 | Other Apoptosis | ||
A c-Met and VEGFR2 inhibitor | |||||
| GC15735 | Foretinib (GSK1363089) | 849217-64-7 | c-MET | ||
Foretinib (GSK1363089)是一种多靶点受体酪氨酸激酶抑制剂,其主要靶点包括c-Met(IC50=0.4nM)和VEGFR2(IC50=0.9nM)。 | |||||
| GC12531 | Cabozantinib malate (XL184) | 1140909-48-3 | Other Apoptosis | ||
A VEGFR2 inhibitor | |||||
| GC17715 | Golvatinib (E7050) | 928037-13-2 | VEGFR | ||
A dual inhibitor of c-Met and VEGFR2 | |||||
| GC11555 | ZM 323881 HCl | 193000-39-4 | VEGFR | ||
A potent and selective VEGFR2 inhibitor | |||||
| GC13833 | BMS-794833 | 1174046-72-0 | VEGFR | ||
An inhibitor of c-Met and VEGFR2 | |||||
| GC17772 | BMS-817378 | 1174161-69-3 | c-MET | ||
Potent ATP competitive inhibitor of Met/VEGFR2 | |||||
| GC62266 | XL092 | 2367004-54-2 | c-MET | ||
XL092 (JUN04542) is an ATP-competitive inhibitor of multiple RTKs including MET, VEGFR2, AXL and MER, with IC50 values of 15 nM, 1.6 nM, 3.4 nM, and 7.2 nM in cell-based assays, respectively. | |||||
